Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
Medical Grand Rounds

Recurrent Clostridioides difficile infection: Recognition, management, prevention

Constantine Tsigrelis, MD
Cleveland Clinic Journal of Medicine June 2020, 87 (6) 347-359; DOI: https://doi.org/10.3949/ccjm.87gr.20001
Constantine Tsigrelis
Department of Infectious Disease, Cleveland Clinic; Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    Antibiotic therapy can paradoxically lead to recurrent Clostridioides difficile infection by disrupting the normal colonic microbiota.

  • Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2

    Photomicrograph showing the presence of Clostridioides difficile bacteria, many of which have assumed an endospore morphology. This is from a blood agar impression smear incubated for 72 hours anaerobically.

    From the US Centers for Disease Control and Prevention, Dr. Gilda Jones; Public Domain; Available at: https://phil.cdc.gov/phil/details.asp?pid=3876

  • Figure 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3

    Fecal microbiota transplantation involves instilling fecal material from a healthy donor to restore the normal intestinal flora.

Tables

  • Figures
    • View popup
    TABLE 1

    Diagnostic tests for Clostridioides difficile

    TestCharacteristicsSensitivity, specificity
    Organism detection assays
    Nucleic acid amplification tests (eg, polymerase chain reaction)Detects toxin gene (ie, organism) but not toxinsHigh sensitivity
    Low to moderate specificity
    Glutamate dehydrogenaseC difficile common antigenHigh sensitivity
    Low specificity
    Toxigenic C difficile cultureGrowth of C difficile organism
    Testing not readily available
    Slow turnaround time
    High sensitivity
    Low specificity
    Toxin detection assays
    Enzyme immunoassayDetects free toxinsLow sensitivity
    Moderate specificity
    Cell culture cytotoxicity neutralization assayDetects free toxins
    Lacks standardization
    Slow turnaround time
    High sensitivity
    High specificity, if optimized
    • Information from McDonald et al, reference 2.

PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 87 (6)
Cleveland Clinic Journal of Medicine
Vol. 87, Issue 6
1 Jun 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Recurrent Clostridioides difficile infection: Recognition, management, prevention
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Recurrent Clostridioides difficile infection: Recognition, management, prevention
Constantine Tsigrelis
Cleveland Clinic Journal of Medicine Jun 2020, 87 (6) 347-359; DOI: 10.3949/ccjm.87gr.20001

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Recurrent Clostridioides difficile infection: Recognition, management, prevention
Constantine Tsigrelis
Cleveland Clinic Journal of Medicine Jun 2020, 87 (6) 347-359; DOI: 10.3949/ccjm.87gr.20001
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • ABSTRACT
    • DIAGNOSIS
    • TREATMENT OF A FIRST EPISODE
    • RECURRENT CDI
    • TREATMENT OF RECURRENT CDI
    • FIDAXOMICIN
    • BEZLOTOXUMAB, A NEWER AGENT
    • FECAL MICROBIOTA TRANSPLANTATION
    • PROBIOTICS
    • PRIMARY AND SECONDARY CDI PROPHYLAXIS
    • TAKE-HOME POINTS
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Emergent metabolic interactions in resistance to Clostridioides difficile invasion
  • Elucidating human gut microbiota interactions that robustly inhibit diverse Clostridioides difficile strains across different nutrient landscapes
  • RelQ-mediated alarmone signaling regulates growth, sporulation, and stress-induced biofilm formation in Clostridioides difficile
  • Google Scholar

More in this TOC Section

  • Steroids in the acutely ill: Evolving recommendations and practice
  • Evaluation and management of orthostatic hypotension: Limited data, limitless opportunity
  • Options for preserving fertility in women undergoing gonadotoxic treatment
Show more Medical Grand Rounds

Similar Articles

Subjects

  • Drug Therapy
  • Gastroenterology
  • Geriatrics
  • Hospital Medicine
  • Infectious Diseases

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire